Clorox (CLX) Q4 2026 earnings review
GOJO Acquisition Masks Severe Organic Weakness
On paper, Clorox's 2% revenue decline looks like a mild contraction. Under the hood, the reality is much harsher. The GOJO (Purell) acquisition injected 10 points of growth, masking a 13% collapse in organic sales. The primary culprit is the anticipated reversal of last year's massive ERP inventory build, which wiped out volumes. However, this destocking shock wreaked havoc on profitability: Gross margin plummeted 520 basis points to 41.3%, and Adjusted EPS fell 42% to $1.66. Management expects a mathematical recovery in FY27 as these ugly comparisons fade, but rebuilding actual consumer volume in a highly promotional environment will be a heavy lift.
🐂 Bull Case
The massive IT transition that distorted shipments and crushed FY26 results is finally complete. Lapping these inventory drawdowns guarantees an automatic >3.5% tailwind to FY27 organic sales.
Adding Purell to the Health & Wellness segment immediately contributed 28 points of segment growth in Q4. It expands Clorox's footprint in a structurally attractive category, providing a much-needed long-term growth engine.
🐻 Bear Case
Total organic volume fell 13% in Q4. Consumers are trading down, moving to smaller sizes, or switching to private label. Pricing actions (+2% mix/price offset) cannot compensate for this level of unit decline.
Gross margins collapsed 520 bps to 41.3%, driven by GOJO inventory step-ups, higher commodities, and manufacturing costs. FY27 guidance of ~42% suggests these pressures are stickier than initially hoped.
⚖️ Verdict: 🔴
Bearish. While the headline numbers look acceptable due to M&A accounting and FY27 guidance mathematically benefits from easy comps, the underlying core business is struggling to move units and maintain pricing power simultaneously.
Key Themes
Household Segment Collapse
The Household division (Bags/Wraps, Cat Litter, Grilling) is bleeding. Sales fell 18% and adjusted EBIT collapsed 56% to $69M. While ERP comparisons explain part of the 16% volume decline, the business is facing intense promotional environments and consumer trade-downs. If core brands like Glad and Fresh Step cannot stabilize volumes without margin-crushing discounts, the overall company recovery is at risk.
Gross Margin Progress Reverses
After quarters of fighting back to a mid-40s gross margin, profitability reversed sharply. Q4 gross margin fell 520 basis points to 41.3%. The drivers were multi-faceted: 150 bps from ERP shipment comparisons, 150 bps from GOJO inventory step-ups, and the rest from elevated manufacturing, logistics, and commodity costs. FY27 guidance of 'about 42%' indicates management expects sustained inflationary headwinds.
GOJO Acquisition Masks Core Weakness
The GOJO (Purell) acquisition closed in April and immediately became the sole engine of top-line stability. It added roughly 10 points to total company sales and 28 points to the Health & Wellness segment. For FY27, it is projected to add 9.5 points of growth. However, it comes with a structural margin drag (lower gross margin, integration costs), making it a double-edged sword: vital for scale, but dilutive to profitability in the near term.
The ERP Boomerang Becomes a Tailwind
The U.S. ERP implementation that devastated FY26 metrics (cutting organic sales by 7.5 points) is finally in the rear-view mirror. As Clorox enters FY27, lapping this artificial inventory drawdown will mechanically add >3.5 points to top-line growth. This base effect guarantees 'growth' next year, but investors must separate this mathematical tailwind from underlying consumer demand.
International is the Only Clean Engine
Amidst the domestic chaos of M&A and IT transitions, the International segment continues to execute cleanly. Net sales rose 4% (organic +1%), and Adjusted EBIT grew 17% in Q4. It proves the company can expand margins through cost savings when uninterrupted by massive domestic structural changes.
Other KPIs
Up from $761M in FY25. Despite the collapse in GAAP net earnings, cash generation improved significantly when adjusting for the $476M Glad Venture termination payment. FCF margin came in at a healthy 13.1%, up from 10.7% last year, providing ample liquidity for the dividend and debt service following the GOJO acquisition.
Accelerating dramatically on a reported basis (+16% YoY), but entirely driven by the GOJO acquisition (+28 points). Underneath the acquisition, organic sales plunged 12%. This segment is undergoing a massive transformation and the real test will be stabilizing the legacy cleaning portfolio while integrating Purell.
Guidance
Accelerating significantly from FY26's 5% decline. This headline number is heavily distorted by two massive tailwinds: ~9.5 points from a full year of GOJO, and >3.5 points from lapping the ERP inventory drawdown. Underlying organic growth is guided much lower at 3.5% to 4.5%.
Accelerating. Implies a 3% to 8% increase from FY26 ($5.53). This growth rate explicitly includes the benefit of the ERP inventory normalization. Given the top-line tailwinds, a single-digit EPS growth guide implies severe ongoing margin compression and higher interest expenses from the GOJO debt.
Stable compared to FY26's 42.3%, but well below the 46.5% peak seen in 25Q4. Management explicitly calls out higher-than-normal inflationary headwinds, negative mix, and a 20 bps ongoing penalty from GOJO inventory step-ups eating through their cost savings.
Key Questions
Path to Gross Margin Recovery
With FY27 gross margin guided at 42%, down significantly from historic mid-40s levels, what is the structural ceiling for margins now that the lower-margin GOJO business is fully integrated?
Household Segment Volume Declines
Organic volume in the Household segment plummeted 16%. How much of this is lingering ERP noise versus permanent market share loss to private label or aggressive competitor promotions in Trash and Litter?
Pricing Power Fatigue
You noted a 'value-seeking consumer' and guided to flat gross margins despite significant cost savings. Have we reached the limit of pricing power across the Clorox portfolio?
GOJO Integration Distraction
With core legacy brands shedding organic volume at double-digit rates, how does management ensure the massive GOJO integration doesn't distract from the urgent operational turnaround needed in Glad and Fresh Step?